Guide for patients & caregivers

What Do LI-RADS Categories Mean on a Liver Scan?

LI-RADS categories on a liver scan explained for people with cirrhosis or hepatitis B: what LR-3, LR-4 and LR-5 mean, usual follow-up and questions to ask.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does a LI-RADS category on a liver scan mean?

A LI-RADS category is a score that describes how likely a spot in the liver is to be benign, to be hepatocellular carcinoma (HCC, the most common type of primary liver cancer) or to be another kind of cancer. Radiologists use it on contrast CT or MRI scans in people at higher risk of liver cancer. The score guides the next step; it is not a final diagnosis on its own.

LI-RADS stands for Liver Imaging Reporting and Data System. It was created so that reports use the same terms and the specialist team can act on them consistently. This guide explains the categories so you can follow your report and discussion with your clinician. LI-RADS is designed for adults with cirrhosis, some people with long-term (chronic) hepatitis B infection, and people who have had HCC before. It is not used for cirrhosis caused by blood vessel problems.

If you do not have these risk factors, a spot found on a scan is usually described in other terms. Our guide on hypodense liver lesions on CT covers that situation. If your team has measured liver scarring with a stiffness test, our FibroScan guide explains those results.

Symptoms that need urgent care

A scan report does not replace getting new symptoms checked. If you have cirrhosis, NHS advice is to call emergency services or go to an emergency department if you are vomiting blood, your poo is very dark or black, or you suddenly become confused or have slurred speech.

  • Ask for an urgent GP appointment or same-day advice if your skin or the whites of your eyes turn yellow.
  • Do the same if you are more short of breath than usual, or your tummy, legs, ankles or feet are swelling.
  • Do not wait for a planned repeat scan if any of these happen.

What do LR-1 to LR-5 mean?

Each spot the radiologist assesses is called an 'observation'. LI-RADS has eight categories. The main ones run on a scale from benign to typical of HCC:

  • LR-1: definitely benign, for example a simple cyst.
  • LR-2: probably benign.
  • LR-3: intermediate likelihood; the spot has some features that need watching but does not fit a clearer group.
  • LR-4: probably HCC.
  • LR-5: definitely HCC on imaging, meaning the spot shows the typical pattern.
  • LR-M: likely a cancer, but without features specific to HCC. Other liver cancers such as cholangiocarcinoma can look like this.
  • LR-TIV: tumour in a vein.
  • LR-NC: not categorisable, used when images are missing or too degraded to assess the spot.

Does LR-3 or LR-4 mean I have liver cancer?

Not necessarily. LR-3 means the features are mixed or not clear enough to place the spot in a firmer group, which is why it is usually watched with another scan. LR-4 means probable rather than certain, so the team weighs options such as biopsy or closer follow-up. Neither category is a diagnosis.

A category describes the scan, not you as a whole person. Your team will read it alongside your liver condition, blood tests such as AFP and any earlier scans. The National Cancer Institute notes that AFP can also be raised by other conditions, including hepatitis and pregnancy, so no single result is read alone.

What features does the radiologist look at?

The main features are size, arterial phase hyperenhancement (the spot lights up brightly early after contrast dye is injected), 'washout' (it looks darker than the liver later on), an enhancing 'capsule' around it, and growth over time. Extra features, such as signal on certain MRI sequences, can move the score up or down, but cannot by themselves raise LR-4 to LR-5.

To be LR-5, a spot must light up in the arterial phase and measure at least 10 mm, along with other major features. That is why a small spot, or one that shows only one feature, often sits in LR-3 or LR-4. A separate version of LI-RADS exists for contrast-enhanced ultrasound (CEUS), and teams sometimes use CEUS to clarify an LR-3 or LR-4 result.

What happens after LR-3, LR-4 or LR-5?

Follow-up is decided by your liver team, often in a multidisciplinary meeting with radiologists, liver specialists, surgeons and oncologists. The general approach described in a review of the system is:

  • LR-3: usually repeat contrast CT or MRI in 3 to 6 months to see whether it changes.
  • LR-4: discussed by the specialist team, who may choose a biopsy, closer follow-up imaging or, in some cases, treatment.
  • LR-5: in people with cirrhosis, HCC can be diagnosed from these typical scan features without a biopsy, so the team moves to staging and treatment planning.
  • LR-M: usually needs a biopsy, because the treatment for other cancer types differs.

How does this fit with 6-monthly ultrasound surveillance?

There is no national liver cancer screening programme in the UK, but Cancer Research UK explains that people at higher risk, such as those with cirrhosis or chronic hepatitis B, may have an ultrasound every 6 months. An AFP (alpha-fetoprotein) blood test may also be done. Our guide on a high AFP result explains that test.

An ultrasound has its own LI-RADS scale (US-1 to US-3). If surveillance ultrasound finds a spot of 10 mm or more that might be HCC (US-3), a contrast CT, MRI or contrast ultrasound follows. That diagnostic scan is where LR-3, LR-4 and LR-5 come from.

Questions to ask your clinician

Bring the written report and any earlier scans. These questions can help you understand the plan.

  • Which spot does the LI-RADS category refer to, and how big is it?
  • Which features set this category, and has it changed since my last scan?
  • Was this a CT, MRI or contrast ultrasound, and would a different scan help?
  • What is the next step, when will it happen and who will contact me?
  • Will my case be discussed at a multidisciplinary meeting?
  • How does my underlying liver condition affect the plan?

How comparing similar cases can help you prepare

On SameCase, patients and verified doctors share de-identified cases. Seeing how other people's LR-3 or LR-4 results were followed up, and which questions they asked, can help you prepare for your own appointment. Every liver and every spot is different, so we do not offer a diagnosis, and similar cases cannot predict your result. Use them to build your question list, then decide next steps with your own liver team.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning